{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:06:14Z","timestamp":1793300774984,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijantimicag.2016.11.032","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T13:31:22Z","timestamp":1486560682000},"page":"488-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report"],"prefix":"10.1016","volume":"49","author":[{"given":"Aasiya","family":"Matin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senu K.","family":"Apewokin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0000000000000012","article-title":"Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature","volume":"93","author":"Anagnostou","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1309\/AJCPW84AFTUWMHYU","article-title":"Nocardiosis in 132 patients with cancer: microbiological and clinical analyses","volume":"142","author":"Wang","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s100960050460","article-title":"Infection caused by Nocardia farcinica: case report and review","volume":"19","author":"Torres","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0025","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case\u2013control study","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/IAI.47.1.135-141.1985","article-title":"Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils","volume":"47","author":"Beaman","year":"1985","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-3062.2010.00588.x","article-title":"In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis","volume":"13","author":"Tripodi","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1179\/joc.2010.22.1.17","article-title":"Linezolid penetration into cerebrospinal fluid and brain tissue","volume":"22","author":"Tsona","year":"2010","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00002018-199615020-00001","article-title":"Neurotoxicity of carbapenem antibacterials","volume":"15","author":"Norrby","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000148914","article-title":"Dose-dense chemotherapy: principles, clinical results and future perspectives","volume":"3","author":"Citron","year":"2008","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0055","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3324\/haematol.2013.085183","article-title":"Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed\/refractory multiple myeloma","volume":"98","author":"Papanikolaou","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0060","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.4049\/jimmunol.158.12.5589","article-title":"Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes","volume":"158","author":"Blotta","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0065","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.161.6.2723","article-title":"Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness","volume":"161","author":"Wu","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/phar.1337","article-title":"Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug","volume":"34","author":"Flanagan","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0075","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1128\/AAC.03423-14","article-title":"Tedizolid population pharmacokinetics, exposure response, and target attainment","volume":"58","author":"Flanagan","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0080","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1128\/AAC.00728-10","article-title":"Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea","volume":"54","author":"Yum","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/13543784.2012.660250","article-title":"Tedizolid (TR-701): a new oxazolidinone with enhanced potency","volume":"21","author":"Kanafani","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0090","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/jac\/dkp314","article-title":"Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages","volume":"64","author":"Vera-Cabrera","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/156720110791560946","article-title":"Evaluation of the combined therapy of DA-7218, a new oxazolidinone, and trimethoprim\/sulfamethoxazole in the treatment of experimental actinomycetoma by Nocardia brasiliensis","volume":"7","author":"Espinoza-Gonzalez","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0100","series-title":"Efficacy and safety results from the ESTABLISH 2 ABSSSI study comparing IV and oral tedizolid phosphate and linezolid","author":"Fang","year":"2013"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/sur.2011.012","article-title":"Disseminated Nocardia farcinica: literature review and fatal outcome in an immunocompetent patient","volume":"13","author":"Budzik","year":"2012","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00019048-199507000-00011","article-title":"Evaluation of therapy for Nocardia asteroides complex infections","volume":"4","author":"McNeil","year":"1995","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0115","series-title":"The safety of single ascending oral doses of TR-701, a novel oxazolidinone prodrug antibiotic","author":"Bien","year":"2009"},{"key":"10.1016\/j.ijantimicag.2016.11.032_bib0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciw241","article-title":"Nocardia infection in solid organ transplant recipients: a multicenter European case\u2013control study","volume":"63","author":"Coussement","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917300390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T04:24:31Z","timestamp":1692678271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917300390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0924857917300390"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.032","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}